News
Media
PodcastsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Sarah Osmundson, MD, MS

Advertisement

Articles by Sarah Osmundson, MD, MS

Society for Maternal-Fetal Medicine Consult Series #50: The role of activity restriction in obstetric management

ByThe Society for Maternal-Fetal Medicine (SMFM),Jhenette Lauder, MD,Anthony Sciscione, DO,Joseph Biggio, MD, MS,Sarah Osmundson, MD, MS
September 9th 2020

Little evidence supports the routine use of activity restriction for preterm birth and other obstetric conditions, and some data indicate adverse impact on obstetric outcomes.

Advertisement

Latest Updated Articles

  • Society for Maternal-Fetal Medicine Consult Series #50: The role of activity restriction in obstetric management
    Society for Maternal-Fetal Medicine Consult Series #50: The role of activity restriction in obstetric management

    Published: September 9th 2020 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

Early estrogen use linked to lower disease risks

2

FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms

3

Clinical insights into vulvar health in menopause, with Melissa Mauskar, MD

4

Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD

5

Caroline Mitchell, MD, highlights safety and flexibility in treating GSM

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us